Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Legius

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2019
Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screeningNathalie Brison, Jazz Storms, Darine Villela, et al.
Human Reproduction (Oxford, England)|January 10, 2023
Preclinical workup using long-read amplicon sequencing provides families with de novo pathogenic variants access to universal preimplantation genetic testingOlga Tsuiko, Yasmine El Ayeb, Tatjana Jatsenko, et al.
Journal of Medical Genetics|November 12, 2018
Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancyManon Suerink, Tim Ripperger, Ludwine Messiaen, et al.
Journal of Medical Genetics|January 15, 2020
The clinical relevance of intragenic <i>NRXN1</i> deletionsNele Cosemans, Laura Vandenhove, Annick Vogels, et al.
Developmental Medicine and Child Neurology|September 28, 2024
Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trialMyrthe J Ottenhoff, Sabine E Mous, Jesminne Castricum, et al.
Genome Biology|June 25, 2014
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpointsJulia Vogt, Kathrin Bengesser, Kathleen B M Claes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 2, 2016
Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidiesNathalie Brison, Kris Van Den Bogaert, Luc Dehaspe, et al.
American Journal of Medical Genetics. Part A|March 26, 2019
From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and SchwannomatosisRosalie E Ferner, Annette Bakker, Ype Elgersma, et al.
Genes, Chromosomes & Cancer|October 12, 2011
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumorsEline Beert, Hilde Brems, Bruno Daniëls, et al.
European Journal of Human Genetics : EJHG|July 27, 2022
Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledgeLore Lannoo, Khaila van Straaten, Jeroen Breckpot, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2019
Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screeningNathalie Brison, Jazz Storms, Darine Villela, et al.
Human Reproduction (Oxford, England)|January 10, 2023
Preclinical workup using long-read amplicon sequencing provides families with de novo pathogenic variants access to universal preimplantation genetic testingOlga Tsuiko, Yasmine El Ayeb, Tatjana Jatsenko, et al.
Journal of Medical Genetics|November 12, 2018
Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancyManon Suerink, Tim Ripperger, Ludwine Messiaen, et al.
Journal of Medical Genetics|January 15, 2020
The clinical relevance of intragenic <i>NRXN1</i> deletionsNele Cosemans, Laura Vandenhove, Annick Vogels, et al.
Developmental Medicine and Child Neurology|September 28, 2024
Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trialMyrthe J Ottenhoff, Sabine E Mous, Jesminne Castricum, et al.
Genome Biology|June 25, 2014
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpointsJulia Vogt, Kathrin Bengesser, Kathleen B M Claes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 2, 2016
Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidiesNathalie Brison, Kris Van Den Bogaert, Luc Dehaspe, et al.
American Journal of Medical Genetics. Part A|March 26, 2019
From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and SchwannomatosisRosalie E Ferner, Annette Bakker, Ype Elgersma, et al.
Genes, Chromosomes & Cancer|October 12, 2011
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumorsEline Beert, Hilde Brems, Bruno Daniëls, et al.
European Journal of Human Genetics : EJHG|July 27, 2022
Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledgeLore Lannoo, Khaila van Straaten, Jeroen Breckpot, et al.
Pageof 17